According to a report by Philstar on December 1st, IQOS, a product under Philip Morris International (PMI), has been launched in the Philippines for 5 years and has made significant progress in encouraging Filipino smokers to switch to smoke-free alternatives.
Dave Gomez, Communications Director of Philip Morris International's (PMI) Philippines subsidiary (PMFTC), revealed to Philstar that as of the second quarter, IQOS has captured 3.8% market share of tobacco users in the Philippines.
IQOS was launched in the Manila area of the Philippines in June 2020 and has since expanded nationwide. Currently, Philippine law prohibits the sale or distribution of cigarettes, e-cigarette devices, and accessories to individuals under the age of 21, as well as bans all advertising, promotions, and sponsorships of these products. Gomez stated that IQOS Philippines must adhere to the Tobacco Regulation Act of 2003 and more recent legislation on e-cigarettes, only promoting its products to adult smokers in controlled environments such as sales points.
Gomez stated that IQOS Philippines is committed to achieving the vision of a "smoke-free Philippines" and plans to continue developing innovative products based on the latest scientific technology to meet consumer demands and regulatory standards.
With the growth in market share and support from favorable regulations, IQOS is in a relatively advantageous position. Gomez stated that the "e-cigarette law" provides a regulatory framework for the company to introduce products and communicate with consumers in the market, while also protecting minors and non-smokers.
"We're actually very happy with our lawmakers. The Vape Law provides the regulatory structure for us to introduce our product in the market, for us to communicate to our consumers, and at the same time, protect minors and protect non-smokers from these labor products," he said.
"We welcome regulation. Regulation is much better than a ban," he said.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
